Medium for cryopreserving hPSC-derived cardiomyocytes.
- Achieve greater than 70% cardiomyocyte viability while maintaining functional capacities
- Supports hPSC-derived cardiomyocytes generated using the STEMdiff™ Cardiomyocyte differentiation kit
STEMdiff™ Cardiomyocyte freezing medium can be used to cryopreserve cardiomyocytes derived from human pluripotent stem cells (hPSCs) and maintained in STEMdiff™ Cardiomyocyte maintenance medium. STEMdiff™ Cardiomyocyte Dissociation Kit is required for dissociating cardiomyocytes prior to freezing. After thawing using STEMdiff™ Cardiomyocyte support medium, the cardiomyocytes can be used in various downstream applications and analyses. This medium supports hPSC-derived cardiomyocytes generated using STEMdiff™ Ventricular Cardiomyocyte differentiation kit or STEMdiff™ Atrial Cardiomyocyte differentiation kit.
Advantages:
Achieve greater than 70% cardiomyocyte viability while maintaining functional capacities
Supports hPSC-derived cardiomyocytes generated using STEMdiff™ Ventricular Cardiomyocyte differentiation kit or STEMdiff™ Atrial Cardiomyocyte differentiation kit
Caution: Product restrictions: (i) Customer shall not make products or any portion of them in any way, shape or form, including as a component of another product available for the purpose of further resale or alter or remove the Product label and the Supplier’s mark of origin without express written permission of Supplier and (ii) Customer is familiar with Supplier’s restrictions on the use of the products and shall use the products in compliance with such restrictions and the applicable Supplier Product Information sheet (collectively, the 'Product Restrictions').